CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. UCB Pharma GmbH

Explore the PTAB proceeding IPR2016-00514 filed by Mylan Pharmaceuticals Inc. et al. on 2016-01-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-00514

Filing Date

2016-01-28

Accorded Filing Date

2016-01-28

Institution Decision Date

2016-07-22

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

2017-07-19

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12105016
Respondent Patent Number 7855230
Legal Expiration Date
2019-08-17 Expired (Term Ended)
Injunction Viability (35 U.S.C. § 283) Statutorily Barred
Respondent Inventor Claus Meese et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Final Decision 2017-07-19
FINAL WRITTEN DECISION - Finding Claims 1–5 Not Unpatentable - Dismissing as Moot Patent Owner’s Motion to Exclude - Granting Joint Motion to Seal and Entering Default Protective Order
35 USC 318, 37 CFR 42.73, 37 CFR 42.5, 37 CFR 42.100

Address and Attorney/Agent Information

11 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Hunton Andrews Kurth LLP/HAK NY
Customer Number 26646
Address 2200 Pennsylvania Avenue NW, Washington, DC, 20037, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
25825 George Badenoch +1 212-908-6185
40074 Tyler Maddry +1 202-955-1964
40131 Gregory Porter +1 713-220-4621
40479 Gary Abelev +1 212-850-2881
41993 William Merone +1 434-962-0261
44487 Yisun Song +1 202-955-1966
54863 Daniel Shanley +1 202-220-4420
59436 Andrew Kasnevich +1 202-662-2770

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 10 proceedings
🏛️
USPTO PTAB Trials 3 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): 🇪🇺 Europe 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (13 found):
PTAB: 3 U.S. Courts: 10
USPTO PTAB Trial 2016-01-28
IPR2016-00512

Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH

U.S. Continuation Sibling (7384980)
Status: Final Written Decision
USPTO PTAB Trial 2016-01-28
IPR2016-00516

Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH

U.S. Continuation Sibling (8338478)
Status: Final Written Decision
USPTO PTAB Trial 2016-01-28
IPR2016-00517

Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH

U.S. Continuation Sibling (7985772)
Status: Final Written Decision
U.S. District Court 2015-11-18
1:15-cv-01067

Pfizer Inc. v. Dr. Reddy's Laboratories Ltd.

Asserted Patent
Status: DED
U.S. District Court 2013-12-11
1:13-cv-02022

Pfizer Inc. v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-12-11
1:13-cv-02021

Pfizer Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-08-02
1:13-cv-01387

Pfizer Inc. v. Wockhardt Bio AG

Asserted Patent
Status: DED
U.S. District Court 2013-06-28
1:13-cv-01156

Pfizer Inc. v. Amerigen Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-06-28
1:13-cv-01155

Pfizer Inc. v. Accord Healthcare Inc.USA

Asserted Patent
Status: DED
U.S. District Court 2013-06-28
1:13-cv-01158

Pfizer Inc. v. Impax Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-06-28
1:13-cv-01154

Pfizer Inc. v. Zydus Pharmaceuticals (USA)Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-06-28
1:13-cv-01153

Pfizer Inc. v. Lupin Ltd

Asserted Patent
Status: DED
U.S. District Court 2013-06-21
1:13-cv-01111

Pfizer Inc. v. Sandoz Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
39

Petition for Review Paper

2017-09-29 FILING PARTY: PETITIONER
38

FINAL WRITTEN DECISION - Finding Claims 1–5 Not Unpatentable - Dismissing as Moot Patent Owner’s Motion to Exclude - Granting Joint Motion to Seal and Entering Default Protective Order Paper

2017-07-19 FILING PARTY: BOARD
37

Record of Oral Hearing Paper

2017-05-03 FILING PARTY: BOARD
35

Order - Conduct of the Proceeding - 37 CFR 42.5 Paper

2017-04-03 FILING PARTY: BOARD
36

Petitioner's Response to Board Inquiry Regarding Lead Counsel Paper

2017-04-03 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc